Presentation is loading. Please wait.

Presentation is loading. Please wait.

A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized.

Similar presentations


Presentation on theme: "A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized."— Presentation transcript:

1 A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections  S. Towfigh, J. Pasternak, A. Poirier, H. Leister, T. Babinchak  Clinical Microbiology and Infection  Volume 16, Issue 8, Pages (August 2010) DOI: /j x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

2 FIG. 1 Study flow diagram. c-mITT, Clinical modified intent-to-treat; CTX/MET, ceftriaxone plus metronidazole; ITT, intent-to-treat; mITT, modified intent-to-treat; TGC, tigecycline. Clinical Microbiology and Infection  , DOI: ( /j x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions


Download ppt "A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized."

Similar presentations


Ads by Google